VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $452,000 | +3.2% | 19,437 | -29.3% | 0.00% | +200.0% |
Q1 2018 | $438,000 | +14.7% | 27,511 | +49.6% | 0.00% | 0.0% |
Q4 2017 | $382,000 | -23.1% | 18,384 | -47.0% | 0.00% | 0.0% |
Q3 2017 | $497,000 | -10.1% | 34,655 | +8.3% | 0.00% | 0.0% |
Q2 2017 | $553,000 | +120.3% | 31,998 | +40.4% | 0.00% | 0.0% |
Q1 2017 | $251,000 | -1.6% | 22,785 | +29.9% | 0.00% | 0.0% |
Q4 2016 | $255,000 | -29.8% | 17,540 | +18.6% | 0.00% | 0.0% |
Q3 2016 | $363,000 | +17.1% | 14,788 | -4.0% | 0.00% | 0.0% |
Q2 2016 | $310,000 | -63.2% | 15,404 | -51.9% | 0.00% | -66.7% |
Q1 2016 | $842,000 | -62.4% | 32,051 | +45.3% | 0.00% | -57.1% |
Q4 2015 | $2,242,000 | -30.9% | 22,055 | +21.2% | 0.01% | -30.0% |
Q3 2015 | $3,246,000 | -48.1% | 18,198 | -35.4% | 0.01% | -33.3% |
Q2 2015 | $6,254,000 | +36.8% | 28,153 | +22.3% | 0.02% | +36.4% |
Q1 2015 | $4,572,000 | +24.2% | 23,018 | -10.5% | 0.01% | +22.2% |
Q4 2014 | $3,681,000 | +57.4% | 25,718 | +44.3% | 0.01% | +50.0% |
Q3 2014 | $2,338,000 | +15.5% | 17,820 | +11.0% | 0.01% | +20.0% |
Q2 2014 | $2,024,000 | -21.2% | 16,050 | -17.7% | 0.01% | -28.6% |
Q1 2014 | $2,569,000 | +58.1% | 19,500 | +40.9% | 0.01% | +40.0% |
Q4 2013 | $1,625,000 | -25.7% | 13,840 | -34.0% | 0.01% | -37.5% |
Q3 2013 | $2,188,000 | -31.6% | 20,970 | -42.5% | 0.01% | -38.5% |
Q2 2013 | $3,198,000 | – | 36,460 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |